Don't forget about TST's cousin, TLTBoth have comparable market caps and both have remedies for NMIBC. But TLT's cure for bladder cancer appears to be far superior.based on the pre-clinical science. The phase 1b trial of its photodynamic compound and reaction-triggering laser could begin as early as next month. If the safety and tolerability study also shows efficacy, TLT will climb like a rocket. GLTLA and DYOD.